‘Global rebates’ made by a multinational pharmaceutical company

A multinational pharmaceutical company which recently had seizure and search from the investigation authorities under suspicion of illegal rebate provision has brought disgrace on itself.

This is because it has aroused suspicion not only in Korea, but in many countries across the world, such as China and Turkey.

The key of the suspicion is it provided rebates to medical institutions as compen...